* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Upper respiratory Tract Infection
Health equity wikipedia , lookup
Public health genomics wikipedia , lookup
Focal infection theory wikipedia , lookup
Rhetoric of health and medicine wikipedia , lookup
Harm reduction wikipedia , lookup
Electronic prescribing wikipedia , lookup
Adherence (medicine) wikipedia , lookup
Dental emergency wikipedia , lookup
Nurse–client relationship wikipedia , lookup
UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER CLINICAL PROTOCOL UPPER RESPIRATORY TRACT INFECTION (URTI)- Common cold, influenza, sore throat, tonsillitis, Practitioner Scope Outcomes Nurse Practitioner (NP) Acute nasal, sinus, ears, pharyngeal and upper airway symptoms in adult and adolescent detainees. Identify clients suitable for Custodial Health Nurse Practitioner (CHNP). Medical Officer (MO) Management of clients not suitable for NP scope of practice (as per above). Underlying complex medical pathology and/or immunocompromised patient Altered conscious state including effects of drugs/ ETOH If quinsy is present, consult MO (may need evacuation / hospitalisation for IV Penicillin and/or surgical drainage of pus) History consistent with collapse Non blanching petechial rash or toxic clinical picture Severe respiratory distress Recent travel in High Risk Area (SARS/Avian Flu) Identify client not suitable for NP and refer to Medical Officer or Emergency Department (ED) of Western Australian Hospital. Page 1 of 11 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER CLIENT ASSESSMENT Activity Assessment Outcome Primary survey assessment • Airway • Breathing • Circulation Abnormal primary survey identified → exit Clinical Protocol (CP) and commence emergency procedures. Presenting History • Time of onset of symptoms • Nature of symptoms- Cough Productive/ non productive, fever, nasal discharge, headache, facial, pharyngeal or ear • pain, ocular symptoms, rash • Ability to function/perform ADL’s • Risk factors • Smoking and/or illicit drug use • Allergies / Immunisation status • Relevant past medical history / medication use particularly asthma, COPD, rheumatic fever or heart disease • Pre-hospital care including GP care, complimentary therapies and pharmacological agents • Other family members affected/ contacts/cell mate • Travel History • Social and work related status. Identify client not suitable for NP CP exit Clinical Protocol (CP) and refer to Medical Officer if required Always be alert to the relationship between group A streptococcal infections and Acute Rheumatic Fever / Acute Post Streptococcal Glomerulonephritis which are especially common in Aboriginal and Torres Strait Island communities The vast majority of URTIs are caused by viruses and do not require antibiotics. A viral upper respiratory tract infection can be complicated by secondary bacterial infection, eg. sinusitis, bronchitis, pneumonia, requiring antibiotics. Other complications include exacerbation of asthma/chronic obstructive pulmonary disease (COPD) Influenza is an acute respiratory illness caused by influenza viruses of which there are many different types. Epidemics commonly occur over the winter months Influenza is probably over-diagnosed. Systemic symptoms such as fever, extreme lethargy, sore muscles and joints and headache differentiate it somewhat from a ‘common cold’ Patients at risk may develop pneumonia secondary to influenza and should be offered influenza and pneumococcal vaccination as per National Immunisation Guidelines and HDWA recommendations Page 2 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER Activity Focused Clinical Assessment Assessment • G eneral appearance and vital signs – respiratory distress, toxicity • Oropharyngeal examination – tonsillar exudate, redness, oedema, stridor, drooling, assess dentition • Palpate sinuses – tenderness, oedema, bogginess • Assess for evidence of rash, arthritis • Palpate for lymphadenopathy, splenomegaly, hepatomegaly • Assess for signs of meningitis –stiff neck, photo phobia, petechial rash, altered conscouis level) • Ear and eye examination • Chest auscultation- Listen to the chest for air entry and added sounds (crackles or wheezes) • Palpate joints for any swelling (if appropriate) Pain Assessment • Pain scale Imaging Imaging not usually required. Consider plain CXR if focal signs on chest examination, fever with productive cough or prolonged symptoms of URTI. Pathology Pathology not routinely required unless: • Suspicion of Infectious Mononucleosis then order monospot, FBP and EBV serology • Throat swab for MC&S if Streptococcal pharyngitis suspected • Consider Nasopharyngeal Aspirate for Pertussis PCR/IgA and serology if Pertussis suspected Outcome Clinical examination finding consistent with diagnosis of Upper Respiratory Tract Infection, ongoing care to be provided by NP. Identify clients not suitable for NP and refer to MO or ED of Western Australian Hospital. Identify differential diagnosis and if necessary manage using alternative CP. Determines need and type of pain relief modalities required. Can guide the NP in determining alternative differential diagnosis. Detect underlying pathology. Identify degree of systemic involvement. Detect underlying pathology. Identify degree of systemic involvement. Page 3 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER INTERPRETATION OF RESULTS AND MANAGEMENT DECISIONS Interpretation of results (diagnostic features) and management decisions Pharyngitis and/or tonsillitis Rhinosinusitis Antibiotic therapy recommended in: • Tonsillitis displaying the 4 diagnostic features suggestive of Streptococcus pyogenes infection: o Fever > 38 C, o tender cervical lymphadenopathy, o tonsillar exudate, and o No cough. • Existing rheumatic fever at any age • Scarlet fever • Peritonsillar cellulitis or quinsy (severe infection of the tonsils causing massive enlargement, evidence of pus on tonsil). Medications as per formulary Pt education /health promotion – symptom relief Follow up appointment with NP if required Consider antibiotics only in severe cases displaying at least 3 of the following; o persistent mucopurulent nasal discharge ( > 7 to 10 days). o Facial pain o Poor response to decongestants o Tenderness over the sinuses, especially unilateral maxillary tenderness o Tenderness on percussion of maxillary molar and premolar teeth that cannot be attributed to a single tooth. Medications as per formulary Pt education /health promotion – symptom relief Follow up appointment with NP if required Outcomes Ensure patient understands problem, treatment, follow-up and when further treatment required. Ensure patient understands problem, treatment, follow-up and when further treatment required. Page 4 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER Interpretation of results (diagnostic features) and management decisions Acute Most often viral and usually does not require antibiotic therapy. Bronchitis • Pertussis should be considered in clients with persistent paroxysmal cough > 2 weeks. Consult MO. May require pernasal aspiration and antibiotics as per formulary. • Pneumonia should be considered in clients with more severe illness • Client education /health promotion • Follow up appointment with NP Outcomes Ensure client understands problem, treatment, follow-up and when further treatment required. Pneumonia Refer to MO or ED of Western Australian Hospital as appropriate. Non specific infection ( all symptoms frequently present but not prominent) moderate/severe pneumonia: if heart rate >120/min, respiratory rate >30/min, cyanosis, hypotension/shock or confusion mild pneumonia: if heart rate <120/min, respiratory rate <30/min, not cyanosed, normal BP and fully orientated · Pt education /health promotion – symptom relief · Consider antibiotics only if symptoms have persisted for >7 days and purulent sputum associated with cough, or nasal discharge · Follow up appointment with NP if required Pertussis is a notifiable disease Pertussis and pneumonia to be referred to MO Ensure client understands problem, treatment, follow up and is safe for discharge home CLIENT SUPPORT Topic When to Return Follow Up Client Education Action Increasingly febrile Not tolerating fluids Symptoms persist for greater than 7 days Reaction to prescribed medication As required by NP or MO Prevention of further recurrences Encourage Influenza and Pneumococcal vaccination as per National Immunisation Guidelines and HDWA recommendations. NP/MO follow up. Adverse drug effects. Outcomes Page 5 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER Topic Referrals Action Health Care Practitioners for issues that lie outside NP Scope of Practice. Outcomes Issues that lie outside NP Scope of Practice will be referred onto appropriate Health Care Practitioners. Page 6 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER PHARMACOLOGY INFORMATION Drug Group Drug Formulary General Information All medication will be stored, labelled and dispensed in accordance with DCS policy and relevant legislation Analgesia Mild pain (unscheduled-S2) Paracetamol Adults and children > 12yrs old: PO 0.5 to 1.0g 4-6hrly not to exceed 4g in 24 hours. Analgesia Moderate Pain (S2-S4) If pain not controlled by paracetamol: Add Ibuprofen Adults: PO 200-400mg TDS or QID up to maximum dose of 2400mg per 24 hours. • If non steroidal anti-inflammatory drugs not suitable or pain poorly controlled refer back to Medical Officer Antiemetics S4 Metoclopramide hydrochloride Oral/IM 10mg 8 hourly Outcomes Client will use the medication in an effective and safe manner. Prescribing NP will be informed of significant adverse effects of medication. Adequate analgesia provided. Client prescribed medication appropriate to known adverse drug reactions, current medications and medical history. Analgesia requirements determined by ongoing assessment of pain. Adequate analgesia provided. Client prescribed medication appropriate to known adverse drug reactions, current medications and medical history. Use ibuprofen with caution in clients with evidence of renal impairment and in the elderly and asthma Analgesia requirements determined by ongoing assessment of pain. Patients with excessive pain or pain unrelieved by analgesia need review by MO Client prescribed medication appropriate to known adverse drug reactions, current medications and medical history. Referral to MO for poorly controlled nausea and vomiting. Joint management by MO and NP may be deemed to be appropriate. Page 7 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER ANTIBIOTIC DRUG FORMULARY Antibiotics S4 Antibiotics Pharyngitis / Tonsillitis Bacterial Sinusitis Non prescription Antibiotic therapy as per drug formulary following. Phenoxymethylpenicillin: 500 mg orally (child: 10 mg/kg up to 500 mg), 12 hourly for 10 days. Should be taken on an empty stomach, ½ to 1hr before meals Hypersensitive to Penicillin use: Roxithromycin: 300 mg orally, daily (child: 4 mg/kg up to 150mg orally, 12 hourly) for 10 days. Should be taken on an empty stomach, ½ to 1hr before meals. Amoxicillin: 500 mg orally (child: 15 mg/kg up to 500 mg), 8 hourly for 5 to 7 days. If hypersensitive to Penicillin use: Cefaclor: 375 mg orally, 12 hourly ( child: 10 mg/kg up to 250mg orally, 8 hourly) for 5 to 7 days OR Doxycycline: 100mg orally (child > 8 yrs: 7.5 mg/kg up to 100mg), daily for 5 to 7 days. Steam Inhalation Antihistamines Gargles- aspirin or warm salt water Page 8 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER Drug Group Drug Formulary Outcomes Adrenaline S3 • • Indicated for use in patients experiencing anaphylaxis. Dosage-for adults and children >12yrs old with spontaneous circulation: 300micrograms (epipen) or 500 micrograms (adrenaline 1:1000) IMlateral thigh repeated every 5 minutes if inadequate resolution of symptoms. Client prescribed medication appropriate to known adverse drug reactions, current medications and medical history. Cetirizine S2 • Indicated for use in patients experiencing cutaneous changes only associated with drug hypersensitivity reaction. Dosage for adults and children> 12 years old: 10mg daily. Route: Oral. Client prescribed medication appropriate to known adverse drug reactions, current medications and medical history. Oxygen therapy will be guided by measured oxygen saturation levels (SaO2). Patients with no history/evidence of chronic lung disease aim for SaO2 > 94%. Oxygen delivery device will be either nasal prongs or face mask. Patients with history of chronic lung disease aim for Sao2 via oxygen delivery device equivalent to baseline SaO2 (if known) otherwise aim for SaO2 >90%. Authorization for use of oxygen therapy to seek to maintain SaO2 > 90%. Transferral of care to MO or ED of WA public hospital. Joint management by MO and NP may be deemed to be appropriate. • • Oxygen Therapy • • • • Page 9 of 11 May 2010 UPPER RESPIRATORY TRACT INFECTION (URTI) CUSTODIAL HEALTH NURSE PRACTITIONER Clinical Protocol Endorsement Name: Fraser Moss Position: Director of Health Services Professional Qualification: Organisation: Signature: Name: Geak Chin Ng Position: Chief Pharmacist Professional Qualification: Organisation: Signature: Name: Julia Chin Position: Nurse Practitioner (Designate) Professional Qualifications: Organisation: Signature: Page 10 of 11 May 2010 Clinical Protocol Name – PRISON HEALTH NURSE PRACTITIONER REFERENCES The Royal College of Pathologists Australia, RCPA Manual, 2004, www.rcpamanual.edu.au. eTG complete Oct 2006. Respiratory Tract Infections [cited 2007 Jan 29]; MIMS. MIMS Online: MIMS, 2005. th Queensland Health and the Royal Flying Doctor Service 2009. Primary Clinical Care Manual (6 Ed.) (Available on-line.) Brown, A.F.T. and Cadogan, M.D. 2006. Emergency Medicine Emergency and Acute Medicine: Diagnosis and Management Medicine (5th Ed), Hodder Arnold, London; DCS would like to thank the Health Department of Western Australia, Joondalup ED and Silver Chain for their assistance in this Clinical Protocol Page 11 of 11